Fig. 7

Patients with cervical cancer having high MICAL2 expression exhibited poor clinical response to radiotherapy. A Among the 62 patients with cervical cancer who underwent radiotherapy, 38 patients achieved a complete response (CR), 17 patients had a partial response (PR), and 7 patients either had stable disease (SD) or experienced disease progression (PD) six months post-radiotherapy. B MICAL2 expression levels in cervical cancer tissues from 2 cases with CR and 1 case with SD, along with their corresponding MRI images (transverse and median sagittal sections) taken before and after radiotherapy. C Kaplan–Meier survival analysis with log-rank test used to assess disease-free progression (DFS) in patients with cervical cancer based on different MICAL2 expression levels (n = 62)